Skip NavigationSkip to Content

SYNTHESIS AND BIOLOGICAL EVALUATION OF INHIBITORS OF BOTULINUM NEUROTOXIN METALLOPROTEASE

  1. Author:
    Wang, C. B.
    Widom, J.
    Petronijevic, F.
    Burnett, J. C.
    Nuss, J. E.
    Bavari, S.
    Gussio, R.
    Wipf, P.
  2. Author Address

    Wang, Chenbo, Widom, Julia, Petronijevic, Filip, Wipf, Peter] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA. [Burnett, James C.] NCI, Target Struct Based Drug Discovery Grp, SAIC Frederick Inc, Frederick, MD 21702 USA. [Nuss, Jonathan E.; Bavari, Sina] USA, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA. [Gussio, Rick] NCI, Informat Technol Branch, Dev Therapeut Program, Frederick, MD 21702 USA.
    1. Year: 2009
  1. Journal: Heterocycles
    1. 79
    2. Pages: 487-520
  2. Type of Article: Article
  1. Abstract:

    Based on the lead therapeutic agent NSC 240898, a new series of heterocyclic inhibitors of the BoNT serotype A metalloprotease has been generated. Highlights of the synthetic sequences include Sonogashira couplings of polysubstituted building blocks and gold-catalyzed indole formations. Preliminary structure-activity relationship studies afford detailed insights into the steric and electrostatic properties of the pharmacophore of this molecular scaffold.

    See More

External Sources

  1. DOI: 10.3987/com-08-s(d)8
  2. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel